-
H-89 for PKA and cAMP Signaling Research
2026-09-15
H-89 is a practical cAMP-dependent protein kinase inhibitor for separating PKA-dependent signaling from downstream metabolic, transcriptional, and phenotypic responses. This guide translates recent Wnt–O-GlcNAcylation findings into controlled workflows for osteogenesis, cell proliferation assays, apoptosis research, and pathway troubleshooting.
-
PF-562271 HCl: FAK/Pyk2 Workflow Guide
2026-09-15
A practical guide to using PF-562271 HCl for reversible FAK/Pyk2 pathway interrogation, from phospho-signaling assays to migration and tumor-model studies. It also shows how radiopathomics findings can inform assay stratification without overstating translational evidence.
-
Molnupiravir Against Bourbon Virus: Mouse Study Insights
2026-09-14
Bamunuarachchi and colleagues show that molnupiravir can suppress Bourbon virus replication and disease in cell culture and a lethal mouse model. The study is notable for combining survival data with tissue viral burden, thrombocytopenia, immune-cell profiles, and liver and spleen pathology, while also testing treatment after infection.
-
Dabigatran Etexilate in Coagulation Research
2026-09-14
Build more interpretable thrombin, plasma, and platelet assays with Dabigatran etexilate, using concentration-response design and prodrug-aware controls. This workflow connects direct pathway interrogation with anticoagulant for atrial fibrillation research while addressing solubility, activation, and assay variability.
-
Parthenolide, ROS, and Apoptosis in Lymphoid Malignancies
2026-09-13
Jorge and colleagues show that parthenolide reduces metabolic activity across diverse B- and T-lineage malignancy models while linking this effect to oxidative stress, glutathione depletion, mitochondrial disruption, and apoptosis. The study’s multi-endpoint design illustrates why a resazurin-based cell viability assay is most informative when paired with flow-cytometric and gene-expression measurements.
-
Norovirus Co-opts NINJ1 for Selective Secretion
2026-09-12
The reference study shows that murine norovirus uses the membrane-rupture factor NINJ1 to release the viral immune-modulatory protein NS1 through an unconventional pathway. By combining CRISPR screening, cell biology, mutagenesis, and mouse infection models, the authors connect caspase-3 activity, NINJ1 oligomerization, and selective viral protein secretion.
-
Plant Protein Secretion: Protocols and pH Readouts
2026-09-12
The second edition of Plant Protein Secretion: Methods and Protocols updates experimental frameworks for analyzing conventional and unconventional secretion in plant cells. Its main contribution is methodological: it connects pathway-specific concepts, plant organelle biology, and reproducible stepwise procedures that can be adapted to trafficking, compartment identity, and intracellular pH studies.
-
DAPT (GSI-IX) in Human Sensory Neuron Assays
2026-09-11
DAPT (GSI-IX) connects γ-secretase inhibition with practical studies of Notch signaling, APP processing, cancer phenotypes, and human sensory-neuron biology. This guide explains how to introduce the compound into hiPSC-derived neuron workflows while separating validated findings from hypothesis-generating applications.
-
Tapuy Lees Protect Neurons in C. elegans Models
2026-09-11
Remucal et al. investigated Tapuy rice wine and its fermentation by-product, Tapuy lees, in Caenorhabditis elegans models of amyloid-β toxicity and dopaminergic neurodegeneration. The study combines behavioral, cellular, biochemical, and LC–MS/MS analyses, finding that both preparations were protective while lees showed the strongest antioxidant profile and overall neuroprotective potential.
-
Angiotensin II: Practical Research Protocols
2026-09-10
This guide provides a controlled workflow for using Angiotensin II in receptor, vascular, cellular, and animal experiments, with emphasis on preparation, dosing, storage, and assay controls. It should support research models of vascular signaling and remodeling, but it is not a substitute for assay-specific validation, medical dosing guidance, or diagnostic use.
-
2-NBDG Glucose Uptake Assay Kit for HCC
2026-09-10
The 2-NBDG Glucose Uptake Assay Kit converts transporter-mediated glucose entry into a non-radioactive fluorescence readout suitable for 96-well screening and single-cell analysis. It offers a practical way to connect sorafenib response, cell viability, and metabolic phenotype in hepatocellular carcinoma models.
-
Structure-Guided Proteomimetics Block SARS-CoV-2 Entry
2026-09-09
The reference study developed constrained proteomimetics that reproduce key human ACE2 recognition elements across the difficult SARS-CoV-2 Spike receptor-binding domain interface. Its lead construct, compound 28, selectively disrupted S-RBD/hACE2 binding, inhibited pseudovirus entry, and showed lung epithelial stability with low permeability, supporting further investigation of localized antiviral delivery.
-
RSL3: GPX4 Inhibition as a Ferroptosis Assay
2026-09-09
RSL3 is a selective glutathione peroxidase 4 inhibitor that exposes redox vulnerabilities in cancer cells. This guide focuses on evidence-based assay design, treatment-resistant prostate cancer, and how to distinguish ferroptosis from nonspecific toxicity.
-
Neuroligin 1 Proteolysis Sustains Social Memory
2026-09-08
Liu and colleagues show that social interaction triggers secretase-dependent cleavage of Neuroligin 1 in the ventral hippocampus, generating an intracellular fragment required for social memory maintenance. By combining genetic, pharmacological, biochemical, behavioral, and spine-imaging approaches, the study links NLG1-CTD, PDZ-domain signaling, and cofilin-dependent synaptic remodeling.
-
AM 281 and the CB1–GLT-1 Translational Axis
2026-09-08
A translational framework for using AM 281 to dissect CB1–CREB–GLT-1 signaling, glutamate excitotoxicity, and cognitive dysfunction after traumatic brain injury.